Prediction role of a novel biomarker ST2 in risk assessment of adverse cardiovascular events in chronic heart failure with preserved and intermediate ejection fraction after myocardial revascularization

相似書籍

• Clinical use of the new biomarker ST2 in patients with chronic heart failure of ischemic genesis: an exercise test
  由: E. V. Grakova, et al.
  出版: (2019-09-01)
• Effect of β-blocker therapy on the level soluble ST2 protein in the blood serum in patients with heart failure with preserved and mildly reduced ejection fraction
  由: E. V. Grakova, et al.
  出版: (2022-04-01)
• Coronary flow reserve in patients with heart failure with preserved ejection fraction
  由: A. V. Mochula, et al.
  出版: (2022-03-01)
• Revascularization in ischemic heart failure with reduced left ventricular ejection fraction. The impact of complete revascularization
  由: Pyka, Łukasz, et al.
  出版: (2017)
• Prognosis of cardiovascular events after implantation of a cardioverterdefibrillator in patients with chronic heart failure: the value of increasing concentration of endothelin-1 and soluble forms of ST2 protein in blood plasma
  由: A. T. Teplyakov, et al.
  出版: (2018-09-01)